INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA FILES APPLICATION FOR "HETEROAROTINOIDS AND/OR CDK4/6 INHIBITORS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED DYSPLASIAS, WARTS AND CANCER IN HPV-INFECTED SUBJECTS"

GENEVA, April 30 -- THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (660 Parrington Oval, Room 119Norman, OK 73019) filed a patent application (PCT/US2024/051215) for "HETEROAROTINOIDS AND/OR CDK4/6 INHIBITORS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED DYSPLASIAS, WARTS, AND CANCER IN HPV-INFECTED SUBJECTS" on Oct 14, 2024. With publication no. WO/2025/085360, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BENBROOK, Doris, M. (12916 Endicott Dr.Oklahoma City, OK 73165)

Abstract: Compositions, drug combinations...